Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > HB Markets SmallCap Newsflash

June 15th, 2010

HB Markets SmallCap Newsflash

Abstract:
Oxford Instruments (LON:OXIG) (OXIG, 270p, £133.84m) Finals to March saw revenues rise marginally to £211.5m (£206.5m) with maintained gross profits of £90.6m (£90.7m) with an underlying operating profit of £14.7m (£13.1m) with reported PBT of £18.1m (loss £9.3m) and an underlying PBT of £11.9m (£11.1m). Adjusted EPS grew to 17.8p (14.8p) aided by a tax charge lower at 27% (35%). The group held its DPS at 8.4p with net debt falling to £10.4m (net debt £28.3m) due to organic cash generation. Underlying operating profits in Nanotechnology fell to £8.2m (£8.6m) on revenues of £101.5m (£93.8m), with Industrial profits returning to a £1m operating profit (loss £1.3m) on revenues down to £71m (£75.1m) with Service revenues increasing to £39m (£37.6m) but with operating profits lower at £5.5m (£5.8m).

Source:
stockopedia.co.uk

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project